← Back to Clinical Trials
Recruiting NCT06284382

NCT06284382 Interaction Between Early Trauma and Odor-induced Dopamine Release

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06284382
Status Recruiting
Phase —
Sponsor Hôpital le Vinatier
Condition Trauma, Psychological
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-04-27
Primary Completion 2028-04-27

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
High score at Childhood Trauma Questionnaire.Low score at Childhood Trauma Questionnaire.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-04-27 with a primary completion date of 2028-04-27.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This prospective, double-blind, parallel-group controlled trial aims to investigate the consequence of early trauma on dopamine release evoked by positive valence odors.

Eligibility Criteria

Inclusion Criteria: * Aged 18 years or older * Have been selected based on the Childhood Trauma Questionnaire score * Non-smoker * Be able to speak and read French * Sign a consent form before intervention. Exclusion Criteria: * A pre-existing condition that affects olfaction including congenital anosmia, upper respiratory tract infection, nasal and/or sinus disease, * Be on medication, with the exception of oral contraceptives * Pregnant or breast-feeding woman (check with urine pregnancy tests); * Contraindications to TMS or MRI (implanted medical devices or metallic foreign body in the head); * Psychiatric disorders * Use of psychotropic drugs * Have participated in a study involving the injection of a radiotracer during the year

Contact & Investigator

Central Contact

FILIPE GALVAO

✉ filipe.galvao@ch-le-vinatier.fr

📞 0033437915565

Principal Investigator

JEROME BRUNELIN

STUDY DIRECTOR

PSYR2

Frequently Asked Questions

Who can join the NCT06284382 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Trauma, Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06284382 currently recruiting?

Yes, NCT06284382 is actively recruiting participants. Contact the research team at filipe.galvao@ch-le-vinatier.fr for enrollment information.

Where is the NCT06284382 trial being conducted?

This trial is being conducted at Bron, France.

Who is sponsoring the NCT06284382 clinical trial?

NCT06284382 is sponsored by Hôpital le Vinatier. The principal investigator is JEROME BRUNELIN at PSYR2. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology